A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease.

A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease.

Item
http://www.wikidata.org/entity/Q36937252
Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementiaThe feasibility and effect of deprescribing in older adults on mortality and health: a systematic review and meta-analysis.Blood lactate levels in patients receiving first- or second- generation antipsychotics.Reconsideration of key articles regarding medication-related problems in older adults from 2011.Relapse risk after discontinuation of risperidone in Alzheimer's disease.Advances in designs for Alzheimer's disease clinical trials.Geriatric psychiatry review: differential diagnosis and treatment of the 3 D's - delirium, dementia, and depression.Management of Behavioral and Psychological Symptoms of Dementia.Dementia, neuropsychiatric symptoms, and the use of psychotropic drugs among older people who receive domiciliary care: a cross-sectional study.Deprescribing antipsychotics for behavioural and psychological symptoms of dementia and insomnia: Evidence-based clinical practice guideline.Evidence and decision algorithm for the withdrawal of antipsychotic treatment in the elderly with dementia and neuropsychiatric symptoms.Behavioral disturbance in dementia.Déprescription des antipsychotiques pour les symptômes comportementaux et psychologiques de la démence et l’insomnie: Guide de pratique clinique fondé sur des données probantes.Neuropsychiatric symptoms of dementia: consent, quality of life, and dignity.Medication monitoring for people with dementia in care homes: the feasibility and clinical impact of nurse-led monitoring
P2860

A 6-month, randomized, double-blind, placebo-controlled pilot discontinuation trial following response to haloperidol treatment of psychosis and agitation in Alzheimer's disease.

Item
http://www.wikidata.org/entity/Q36937252
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
A 6-month, randomized, double- ...... tation in Alzheimer's disease.
@en
type
label
A 6-month, randomized, double- ...... tation in Alzheimer's disease.
@en
prefLabel
A 6-month, randomized, double- ...... tation in Alzheimer's disease.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
A 6-month, randomized, double- ...... tation in Alzheimer's disease.
@en
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932